Protease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury. 2010

Silvio Antoniak, and Mauricio Rojas, and Denise Spring, and Tara A Bullard, and Edward D Verrier, and Burns C Blaxall, and Nigel Mackman, and Rafal Pawlinski
Division of Hematology/Oncology, Department of Medicine, UNC McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7035, USA.

OBJECTIVE To investigate the effect of protease-activated receptor (PAR) 2 deficiency on ischemia/reperfusion (I/R) injury-induced infarct size, inflammation, heart remodeling, and cardiac function. RESULTS PAR-2 signaling enhances inflammation in different diseases. The effect of PAR-2 deficiency in cardiac I/R injury is unknown. PAR-2(-/-) mice and wild-type littermates were subjected to 30 minutes of ischemia and up to 4 weeks of reperfusion. Infarct size, oxidative/nitrative stress, phosphorylation of mitogen-activated protein kinases, and inflammatory gene expression were assessed 2 hours after reperfusion. Changes in heart size and function were measured by echocardiography up to 4 weeks after reperfusion. Infarct size was significantly reduced in hearts of PAR-2(-/-) mice compared with wild-type littermates. In addition, oxidative/nitrative stress, phosphorylation of mitogen-activated protein kinase, and expression of proinflammatory genes were significantly attenuated in injured hearts of PAR-2(-/-) mice. Finally, PAR-2(-/-) mice were protected from postinfarction remodeling and showed less impairment in heart function compared with wild-type littermates up to 4 weeks after I/R injury. CONCLUSIONS PAR-2 deficiency reduces myocardial infarction and heart remodeling after I/R injury.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015428 Myocardial Reperfusion Injury Damage to the MYOCARDIUM resulting from MYOCARDIAL REPERFUSION (restoration of blood flow to ischemic areas of the HEART.) Reperfusion takes place when there is spontaneous thrombolysis, THROMBOLYTIC THERAPY, collateral flow from other coronary vascular beds, or reversal of vasospasm. Reperfusion Injury, Myocardial,Injury, Myocardial Reperfusion,Myocardial Ischemic Reperfusion Injury,Injuries, Myocardial Reperfusion,Myocardial Reperfusion Injuries,Reperfusion Injuries, Myocardial

Related Publications

Silvio Antoniak, and Mauricio Rojas, and Denise Spring, and Tara A Bullard, and Edward D Verrier, and Burns C Blaxall, and Nigel Mackman, and Rafal Pawlinski
January 2016, Journal of molecular and cellular cardiology,
Silvio Antoniak, and Mauricio Rojas, and Denise Spring, and Tara A Bullard, and Edward D Verrier, and Burns C Blaxall, and Nigel Mackman, and Rafal Pawlinski
March 2000, Proceedings of the National Academy of Sciences of the United States of America,
Silvio Antoniak, and Mauricio Rojas, and Denise Spring, and Tara A Bullard, and Edward D Verrier, and Burns C Blaxall, and Nigel Mackman, and Rafal Pawlinski
January 2011, Molecular medicine reports,
Silvio Antoniak, and Mauricio Rojas, and Denise Spring, and Tara A Bullard, and Edward D Verrier, and Burns C Blaxall, and Nigel Mackman, and Rafal Pawlinski
January 2021, Frontiers in pharmacology,
Silvio Antoniak, and Mauricio Rojas, and Denise Spring, and Tara A Bullard, and Edward D Verrier, and Burns C Blaxall, and Nigel Mackman, and Rafal Pawlinski
November 2012, The journal of trauma and acute care surgery,
Silvio Antoniak, and Mauricio Rojas, and Denise Spring, and Tara A Bullard, and Edward D Verrier, and Burns C Blaxall, and Nigel Mackman, and Rafal Pawlinski
December 2009, American journal of physiology. Regulatory, integrative and comparative physiology,
Silvio Antoniak, and Mauricio Rojas, and Denise Spring, and Tara A Bullard, and Edward D Verrier, and Burns C Blaxall, and Nigel Mackman, and Rafal Pawlinski
November 2019, Experimental and therapeutic medicine,
Silvio Antoniak, and Mauricio Rojas, and Denise Spring, and Tara A Bullard, and Edward D Verrier, and Burns C Blaxall, and Nigel Mackman, and Rafal Pawlinski
December 2022, Molecular medicine (Cambridge, Mass.),
Silvio Antoniak, and Mauricio Rojas, and Denise Spring, and Tara A Bullard, and Edward D Verrier, and Burns C Blaxall, and Nigel Mackman, and Rafal Pawlinski
November 2012, The Journal of nutritional biochemistry,
Silvio Antoniak, and Mauricio Rojas, and Denise Spring, and Tara A Bullard, and Edward D Verrier, and Burns C Blaxall, and Nigel Mackman, and Rafal Pawlinski
October 2019, European heart journal,
Copied contents to your clipboard!